Abstract
Osteoporosis is a chronic disease affecting mostly women of post-menopausal age and characterized by bone mass
loss and skeletal micro-architecture alteration, all conditions that imply significant consequences in terms of both
mortality and disability. Direct healthcare costs for hospitalization, outpatient treatment and nursing home
admissions saddle governments with a significant burden, which is destined to increase with population aging.
Evidence exists on cost-effectiveness of osteoporosis treatment in reducing the risk of refracture, with positive
effects not only for healthcare expenditure, but also in terms of premature mortality, reduced quality of life and
autonomy loss. With the help of relevant literature, this paper analyses the economic and social burden of
osteoporosis and provides policy measures to both reduce the risk of fragility fractures among the elderly and
diminish the economic load on societies
| Original language | English |
|---|---|
| Pages (from-to) | 1-9 |
| Number of pages | 9 |
| Journal | INTERNATIONAL JOURNAL OF BUSINESS AND SOCIAL SCIENCE |
| Volume | 12 |
| Issue number | 6 June 2021 |
| DOIs | |
| Publication status | Published - 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Burden of disease
- Fragility fractures
- Osteoporosis
- Population aging
- Social costs
Fingerprint
Dive into the research topics of 'The Economic and Social Burden of Osteoporosis in Developed Countries: Health Policy Considerations Based on a Literature Review'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver